Advertisement

Senticare Inc.’s Pillstation technology, made to help patients adhere to medication regimens, is currently being tested in trials by the New York City Department of Health, Columbia University and Massachusetts General Hospital.

The Southborough-based medical device company will test the system on patients with three separate illnesses where non- adherence has been shown to result in deteriorating health and dramatically higher costs – HIV/AIDS, post-acute coronary syndrome and serious depression.

SOURCE

Advertisement
Advertisement